UNSPSC 51313001: Azelastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H24ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZQI909440X, chemically known as 1(2h)-phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)- but generally known as azelastine, which bears US NIH Compound Identifier 2267. Azelastine most often comes in base and hydrochloride forms.

UNSPSC 51313001 Azelastine, a Commodity code, nominally covers a single antihistamine product, but recent state and local solicitations tagged under this code show no activity for azelastine itself. Instead, the opportunities reflect procurement of naloxone, safe drug deactivation systems, broad pharmaceutical portfolios including generic multi-source drugs and over-the-counter products, and exploratory contracting for direct-to-manufacturer prescription fulfillment models. State and local governments buying under this code span county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The mismatch between the code's nominal scope and actual solicitation content suggests that either the code is being misapplied to pharmaceutical procurement generally, or the recent opportunities are tagged incorrectly and do not represent genuine azelastine demand.

Recent activity includes Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, response due July 26, 2023; Texas HHS Commission's Request for Information on direct-to-manufacturer prescription programs, posted April 3, 2026; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota, Oregon, and other jurisdictions, responses due March 26, 2026. Geographic activity centers on Florida, Texas, and the Upper Midwest through the cooperative purchasing vehicle. Without evidence that azelastine itself is actually being procured under this code by state and local buyers, the code shows little relevant recent activity aligned to its stated commodity name.